Autoantibodies Neutralizing Type I INFs May Be Associated with Efficacy of Tocilizumab in COVID-19 Pneumonia
- Resource Type
- Letter
- Source
- Journal of Clinical Immunology: International Journal of Inborn Errors of Immunity and Related Diseases. 42(6):1107-1110
- Subject
- Language
- English
- ISSN
- 0271-9142
1573-2592